• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Vinylogous acids Vinylogous acids
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Vinylogous acids
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Comprehensive Overview of Albaspidin AA (CAS No. 3570-40-9): Properties, Applications, and Research Insights

Albaspidin AA (CAS No. 3570-40-9) is a naturally occurring phloroglucinol derivative, primarily isolated from the rhizomes of Dryopteris species. This bioactive compound has garnered significant attention in recent years due to its potential therapeutic properties, including antimicrobial, anti-inflammatory, and antioxidant activities. Researchers and pharmaceutical developers are increasingly exploring Albaspidin AA as a promising candidate for nutraceutical and cosmeceutical applications, aligning with the growing consumer demand for plant-based bioactive ingredients.

The chemical structure of Albaspidin AA features a unique phloroglucinol core, which contributes to its diverse biological activities. Studies have shown that this compound exhibits strong inhibitory effects against gram-positive bacteria, making it a subject of interest in the context of antibiotic resistance—a critical global health concern. With the rise of natural antimicrobial agents as alternatives to synthetic antibiotics, Albaspidin AA has emerged as a focal point in microbiological research.

In dermatology and skincare, Albaspidin AA is being investigated for its potential to mitigate oxidative stress and inflammation, two key factors in skin aging and chronic dermatological conditions. The compound's ability to scavenge free radicals aligns with the booming market for anti-aging skincare ingredients, particularly those derived from botanical sources. Cosmetic formulators are actively evaluating its stability and efficacy in topical formulations, responding to consumer preferences for clean-label and sustainable beauty products.

From a pharmacological perspective, preliminary studies suggest that Albaspidin AA may modulate cellular signaling pathways involved in inflammatory responses. This has sparked interest in its potential application for managing chronic inflammatory disorders, a research area gaining traction due to the increasing prevalence of autoimmune diseases worldwide. However, further clinical trials are necessary to validate these findings and establish safety profiles for human use.

The extraction and purification of Albaspidin AA present technical challenges due to its relatively low abundance in natural sources. Recent advancements in green extraction technologies, such as supercritical fluid extraction and ultrasound-assisted methods, are being explored to improve yield and sustainability. These innovations cater to the pharmaceutical industry's push toward environmentally friendly production processes—a topic frequently searched by professionals in the field.

Analytical characterization of Albaspidin AA typically involves techniques like HPLC-MS and NMR spectroscopy, which provide detailed insights into its purity and structural integrity. Quality control protocols for this compound are critical, especially given the stringent regulatory requirements for bioactive ingredients in pharmaceuticals and cosmetics. Researchers often search for standardized analytical methods for phloroglucinol derivatives, highlighting the need for established reference materials.

In the realm of traditional medicine, plants containing Albaspidin AA have been used for centuries in various cultural practices. Modern scientific validation of these traditional uses represents an exciting convergence of ethnopharmacology and contemporary drug discovery—a subject that frequently appears in academic searches. This historical context adds depth to current research efforts while providing leads for potential therapeutic applications.

The stability of Albaspidin AA under different environmental conditions remains an active area of investigation. Formulation scientists are particularly interested in its degradation kinetics and optimal storage conditions, as these factors directly impact product shelf life and efficacy. Such practical considerations are crucial for translating laboratory findings into commercially viable products, addressing common queries from industry professionals.

As research on Albaspidin AA progresses, intellectual property considerations are coming to the forefront. Patent analyses reveal growing interest in novel extraction methods, synthetic analogs, and specific therapeutic applications of this compound. This legal dimension is increasingly relevant for companies operating in the competitive landscape of natural product development.

Looking ahead, the scientific community anticipates more comprehensive toxicological studies and mechanism-of-action research on Albaspidin AA. These investigations will be pivotal in determining its therapeutic potential and safety profile, addressing key questions frequently posed by researchers and regulatory bodies alike. The compound's journey from laboratory curiosity to clinically validated ingredient exemplifies the complex pathway of natural product development in modern science.

• 139409-37-3(2,5-Cyclohexadien-1-one, 4,4-diethyl-3,5-dihydroxy-2,6-bis(2-methyl-1-oxopropyl)-)
• 644-61-1(2,5-Cyclohexadien-1-one,2,2'-methylenebis[3,5-dihydroxy-4,4-dimethyl-6-(1-oxobutyl)-)
• 832109-85-0(2,5-Cyclohexadiene-1,4-dione, (1,1-dimethylethyl)hydroxy-)
• 101386-00-9(2-(1-hydroxy-2-methylpropylidene)cyclohexane-1,3-dione)
• 139409-39-5(2,5-Cyclohexadien-1-one, 3,5-dihydroxy-2,6-bis(2-methyl-1-oxopropyl)-4,4-dipentyl-)
• 139409-38-4(2,5-Cyclohexadien-1-one,4,4-dibutyl-3,5-dihydroxy-2,6-bis(2-methyl-1-oxopropyl)-)
• 103766-17-2(2,5-Cyclohexadiene-1,4-dione, 2-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-3,5-dihydroxy-6-(2-methyl-1-oxopropyl)-)
• 52755-22-3(2,5-Cyclohexadien-1-one,3,5-dihydroxy-2,4,4-tris(3-methylbutyl)-6-(2-methyl-1-oxopropyl)-)
• 652153-12-3(1,4-Cyclohexadiene-1-carboxaldehyde,4-methoxy-3,3-dimethyl-6-oxo-)
• 137919-99-4(Cyclohexanone, 2-(1-hydroxy-2,2-dimethylpropylidene)-, (Z)-)